SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced U.S. Food and Drug Administration (FDA) clearance of ...

In recent years, diabetes advocacy groups have called for greater attention to measures beyond glycated hemoglobin when evaluating diabetes drugs, because avoiding hypoglycemia and spending more time ...

Adults with type 2 diabetes who used an automated insulin delivery system had greater improvements in HbA1c than controls ...

An incredible proof-of-concept study from a team of European scientists has demonstrated the development of a novel insulin molecule that can sense blood sugar levels and self-adjust its activity in ...

Growing diabetes prevalence, with over 540 million diagnosed individuals worldwide, and the increasing adoption of continuous subcutaneous insulin infusion (CSII) therapy are fueling market demand.

Jaeb Center for Health Research conducted a randomized controlled trial evaluating the impact of automated insulin delivery (AID) in adults with insulin-treated type 2 diabetes. AID significantly ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The first trial of semaglutide in patients with type 1 ...

For diabetics who blame rice as the root cause of their problems, a diabetes specialist clarified that other factors, like ...

A new software system that will let people with diabetes customize their treatment and automatically adjust their insulin levels was just approved for use by the Food and Drug Administration. It will ...